These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27773847)

  • 21. The influence of soil heavy metals pollution on soil microbial biomass, enzyme activity, and community composition near a copper smelter.
    Wang Y; Shi J; Wang H; Lin Q; Chen X; Chen Y
    Ecotoxicol Environ Saf; 2007 May; 67(1):75-81. PubMed ID: 16828162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary cadmium intake and risk of prostate cancer: a Danish prospective cohort study.
    Eriksen KT; Halkjær J; Meliker JR; McElroy JA; Sørensen M; Tjønneland A; Raaschou-Nielsen O
    BMC Cancer; 2015 Mar; 15():177. PubMed ID: 25884961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
    Ozkan EE
    Mol Cell Endocrinol; 2011 Sep; 344(1-2):1-24. PubMed ID: 21782884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of Polyphenols Against Carcinogenesis Induced by Environmental Carcinogens.
    Clementino M; Shi X; Zhang Z
    J Environ Pathol Toxicol Oncol; 2017; 36(1):87-98. PubMed ID: 28605333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing potential dietary toxicity of heavy metals in selected vegetables and food crops.
    Islam Eu; Yang XE; He ZL; Mahmood Q
    J Zhejiang Univ Sci B; 2007 Jan; 8(1):1-13. PubMed ID: 17173356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond.
    Nakazawa M; Kyprianou N
    J Steroid Biochem Mol Biol; 2017 Feb; 166():84-90. PubMed ID: 27189666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review for clinicians: Prostate cancer and the antineoplastic properties of metformin.
    Hankinson SJ; Fam M; Patel NN
    Urol Oncol; 2017 Jan; 35(1):21-29. PubMed ID: 27836248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicogenomic approaches for understanding molecular mechanisms of heavy metal mutagenicity and carcinogenicity.
    Koedrith P; Kim H; Weon JI; Seo YR
    Int J Hyg Environ Health; 2013 Aug; 216(5):587-98. PubMed ID: 23540489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).
    Narayanan BA; Condon MS; Bosland MC; Narayanan NK; Reddy BS
    Clin Cancer Res; 2003 Aug; 9(9):3503-13. PubMed ID: 12960143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The biochemical carcinogenesis of selected heavy metals in bladder cancer].
    Rorbach-Dolata A; Marchewka Z; Piwowar A
    Postepy Biochem; 2015; 61(2):176-82. PubMed ID: 26689010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostate cancer and apoptosis].
    Mayora A; Arvelo F
    Invest Clin; 2011 Dec; 52(4):376-96. PubMed ID: 22523847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: A general review of metal mixture mechanism in brain.
    Karri V; Schuhmacher M; Kumar V
    Environ Toxicol Pharmacol; 2016 Dec; 48():203-213. PubMed ID: 27816841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.
    Bonkhoff H
    Prostate; 2018 Jan; 78(1):2-10. PubMed ID: 29094395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical review of the bioavailability and impacts of heavy metals in municipal solid waste composts compared to sewage sludge.
    Smith SR
    Environ Int; 2009 Jan; 35(1):142-56. PubMed ID: 18691760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heavy metal induced oxidative stress & its possible reversal by chelation therapy.
    Flora SJ; Mittal M; Mehta A
    Indian J Med Res; 2008 Oct; 128(4):501-23. PubMed ID: 19106443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of CYP17A1 in prostate cancer development: structure, function, mechanism of action, genetic variations and its inhibition.
    Kmeťová Sivoňová M; Jurečeková J; Tatarková Z; Kaplán P; Lichardusová L; Hatok J
    Gen Physiol Biophys; 2017 Dec; 36(5):487-499. PubMed ID: 29372682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.
    Denmeade SR; Lin XS; Isaacs JT
    Prostate; 1996 Apr; 28(4):251-65. PubMed ID: 8602401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of 17β-hydroxysteroid dehydrogenase type 3 as a target in hormone-dependent prostate cancer therapy.
    Ning X; Yang Y; Deng H; Zhang Q; Huang Y; Su Z; Fu Y; Xiang Q; Zhang S
    Steroids; 2017 May; 121():10-16. PubMed ID: 28267564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy.
    Huang CN; Huang SP; Pao JB; Hour TC; Chang TY; Lan YH; Lu TL; Lee HZ; Juang SH; Wu PP; Huang CY; Hsieh CJ; Bao BY
    J Intern Med; 2012 May; 271(5):499-509. PubMed ID: 21880074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.